Disposable Syringes

Global Disposable Syringes Market to Reach US$21.9 Billion by 2030

The global market for Disposable Syringes estimated at US$15.4 Billion in the year 2024, is expected to reach US$21.9 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Safety Syringes, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$15.0 Billion by the end of the analysis period. Growth in the Conventional Syringes segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.1 Billion While China is Forecast to Grow at 9.8% CAGR

The Disposable Syringes market in the U.S. is estimated at US$4.1 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.0 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Disposable Syringes Market - Key Trends & Drivers Summarized

Why Are Disposable Syringes Becoming Indispensable in Healthcare?

Disposable syringes have become a critical component in the healthcare sector, playing a pivotal role in ensuring patient safety and minimizing the risk of infections. These single-use devices are designed to prevent cross-contamination, a crucial aspect in medical settings where sterilization and hygiene are of utmost importance. The widespread use of disposable syringes in vaccination programs, medication administration, and blood sample collection underscores their significance. With the rise in chronic diseases, an aging global population, and the expansion of healthcare services in developing regions, the demand for disposable syringes has escalated. Additionally, the ongoing focus on infection prevention and control in healthcare facilities is propelling the use of these products, which are vital for safe and efficient medical procedures.

How Have Technological and Manufacturing Advancements Improved Disposable Syringes?

The disposable syringe market has benefited from technological advancements in materials and manufacturing processes, resulting in improved safety features and efficiency. The development of auto-disable (AD) syringes, designed to prevent reuse and thus reduce the risk of transmission of blood-borne infections, has gained traction, especially in vaccination and immunization campaigns. The use of biocompatible and biodegradable materials is also emerging, aligning with global sustainability trends and reducing environmental impact. Furthermore, advances in manufacturing automation have improved production capacity and quality control, ensuring a consistent supply of reliable syringes. Smart syringes that integrate RFID technology for tracking and monitoring usage are also being developed, adding an extra layer of control in healthcare settings. These technological advancements enhance the safety, effectiveness, and sustainability of disposable syringes, driving their adoption worldwide.

Where Are Disposable Syringes Most Widely Used?

Disposable syringes are utilized extensively across various segments of healthcare, with their applications spanning hospitals, clinics, vaccination programs, and home care settings. Hospitals and clinics remain the largest consumers, using these syringes for medication administration, blood collection, and intravenous procedures. In public health, mass vaccination campaigns rely heavily on disposable syringes, particularly in developing regions where efforts to control diseases like measles, polio, and, most recently, COVID-19, have led to large-scale use. Additionally, diabetic patients and other individuals requiring regular injections often use disposable syringes for insulin administration and self-care at home. Veterinary applications also form a significant segment, where disposable syringes are employed in the care and treatment of animals. The versatility and importance of disposable syringes in various healthcare settings highlight their indispensable role in modern medicine.

What Factors Are Driving the Growth of the Disposable Syringes Market?

The growth in the disposable syringes market is driven by several factors, including rising healthcare needs, technological advancements, and global vaccination initiatives. The increase in chronic diseases such as diabetes, which require regular injections, and the rising geriatric population contribute to the heightened demand for these products. The global focus on immunization and vaccination campaigns, especially in response to infectious diseases and pandemics, has also led to a surge in disposable syringe consumption. Furthermore, the emphasis on infection control in healthcare facilities drives the preference for single-use syringes, ensuring patient safety and compliance with medical standards. Technological innovations, such as the development of auto-disable and smart syringes, are enhancing safety measures and reducing the risks associated with needle reuse, propelling market growth further. The expansion of healthcare infrastructure in emerging markets, coupled with government support for vaccination programs, continues to bolster the demand for disposable syringes globally.

SCOPE OF STUDY:

The report analyzes the Disposable Syringes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Safety Syringes, Conventional Syringes); Application (Therapeutic Injections, Immunization Injections)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• B. Braun Melsungen AG
• Becton, Dickinson & Company
• Medtronic PLC
• Retractable Technologies, Inc.
• Smiths Medical
• Terumo Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.